Novartis Lawsuit Accuses Pharma Giant Of Huge Kickback Scheme

There may be more going on behind the counter of your local pharmacy than you think.

On Tuesday, the U.S. government sued big-name Swiss multinational Novartis Pharmaceuticals Corporation for its violation of the federal anti-kickback statute. The statute prohibits the offer or payment of rebates and other inducements to cause the purchase of any drug or service covered by Medicare, Medicaid or other health care program; Novartis had allegedly been making just those offers.

According to the lawsuit, Novartis disguised kickbacks as performance rebates and discounts to convince pharmacies to get their patients to switch over to Myfortic — Novartis’ internationally-selling drug designed to keep the body from rejecting its new organ after a kidney transplant. These kickbacks, the government asserts, have caused the public to pay tens of millions of dollars for drugs dispensed by pharmacists who had buddied up to Novartis, and have at the same time awarded particular pharmacists several hundred thousand dollars to "shoulder the burden" of switching 700 to 1,000 transplant patients to Myfortic.

Novartis denied the government accusation, saying that “NPC is committed to high standards of ethical business conduct and regulatory compliance in the sale and marketing of [its] products."

But this isn’t the first time that Novartis has faced legal controversy.

In 2008, the company got in trouble with the Food and Drug Administration for overstating the efficacy of its Focalin XR ADHD drug. In 2009, the company declined to provide free vaccines to the poor in order to counter a chronic flu epidemic, saying developing nations or donor nations should have covered the costs. In 2010, the company paid sexual discrimination penalties of over $3.3 million. And then later in that same year the company also forked over $422.5 million in criminal and civil claims for fraud charges.

But, from the company’s standpoint, these penalties and the 10% to20% alleged kickback fees to pharmacists who were switching transplant patients this year are, in the end, still profitable. The company ranked second among the worldwide pharmaceutical industry in sales in 2010 with an estimated $46.806 billion.

So, next time you go to pick up your prescription from your ole’, trusty pharmacist and he suggests a new brand of medication for you to try instead, just know that somewhere underneath that counter top may be the influential hands of some multinational behemoth pulling at your pharmacist’s pant leg to get you to change prescriptions.

How much do you trust the information in this article?

Addison Williams

Undergraduate Georgetown University student studying Government with a concentration in Foreign Affairs. Hailing from Boston, MA but with a heart that will forever lie in the mountains. Sports, politics, music, theater, art, and hip hop culture are of interest. Eclectic, I guess, would suffice.

MORE FROM

Amid new revelations, here’s what we’ve learned about the Russian lawyer who met with Trump Jr.

The picture of Natalia Veselnitskaya is coming into clearer focus.

Republican Senator urges whoever leaked Russia/Sessions phone calls to release whole conversation

Sen. Chuck Grassley wants the person who leaked intelligence about Attorney General Jeff Sessions and Russian ambassador Sergey Kislyak to come forward with more information.

Donald Trump Jr. and Paul Manafort now to testify before Senate committee behind closed doors

Trump Jr. and Manafort have avoided a subpoena and will testify behind closed doors — for now.

Hope Hicks reportedly tried to rein Trump in during explosive ‘Times’ interview. It didn’t work.

The low-profile Trump Whisperer is one of the few in the president's orbit to enjoy job security.

Scaramucci once asked Obama if he’d be softer on Wall Street. It didn’t end well.

The exchange came during a CNBC town hall on the financial crisis, two years into Obama’s presidency.

Trump blasts Hilary Clinton, Comey and ‘Amazon Washington Post’ in tweet storm

He also defended Don Jr. and called Democrats "obstructionists" with "no ideas."

Amid new revelations, here’s what we’ve learned about the Russian lawyer who met with Trump Jr.

The picture of Natalia Veselnitskaya is coming into clearer focus.

Republican Senator urges whoever leaked Russia/Sessions phone calls to release whole conversation

Sen. Chuck Grassley wants the person who leaked intelligence about Attorney General Jeff Sessions and Russian ambassador Sergey Kislyak to come forward with more information.

Donald Trump Jr. and Paul Manafort now to testify before Senate committee behind closed doors

Trump Jr. and Manafort have avoided a subpoena and will testify behind closed doors — for now.

Hope Hicks reportedly tried to rein Trump in during explosive ‘Times’ interview. It didn’t work.

The low-profile Trump Whisperer is one of the few in the president's orbit to enjoy job security.

Scaramucci once asked Obama if he’d be softer on Wall Street. It didn’t end well.

The exchange came during a CNBC town hall on the financial crisis, two years into Obama’s presidency.

Trump blasts Hilary Clinton, Comey and ‘Amazon Washington Post’ in tweet storm

He also defended Don Jr. and called Democrats "obstructionists" with "no ideas."